Scott A. Gangloff - Apr 29, 2024 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: Chief Technology Officer
Signature: /s/ Jonathan Young, Attorney-in-fact
Stock symbol: AKRO
Transactions as of: Apr 29, 2024
Transactions value $: $0
Form type: 3
Date filed: 5/1/2024, 07:32 PM

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney